Part 2: Making the “unproven” “proven”-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Part 2: Making the “unproven” “proven”

Published:2016-01 Issue:1 Volume:18 Page:120-123
ISSN:1465-3249
Container-title:Cytotherapy
language:en
Short-container-title:Cytotherapy

Author:

Weiss Daniel J.,Rasko John E.J.,Cuende Natividad,Ruiz Milton A.,Ho Hong-Nerng,Nordon Robert,Wilton Steve,Dominici Massimo,Srivastava Alok

Publisher

Elsevier BV

Subject

Cancer Research,Transplantation,Cell Biology,Genetics(clinical),Oncology,Immunology,Immunology and Allergy

Reference12 articles.

1. Advancing stem cell therapy from bench to bedside: lessons from drug therapies;Srijaya;J Transl Med,2014

2. Regulatory agency concerns in the manufacturing and testing of monoclonal antibodies for therapeutic use;Baker;Targeted Diagn Ther,1990

3. Medical innovation versus stem cell tourism;Lindvall;Science,2009

4. Advancing stem cell biology toward stem cell therapeutics;Scadden;Cell Stem Cell,2012

5. Potency assay development for cellular therapy products: an ISCT review of the requirements and experiences in the industry;Bravery;Cytotherapy,2013

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Ethical considerations for the use of stem cell-derived therapies;Phenotyping of Human iPSC-derived Neurons;2023

2. Proven and unproven cell therapies – what we have learned so far?;ISBT Science Series;2021-05-11

3. The Future of Regenerative Medicine;Regenerative Medicine for Spine and Joint Pain;2020

4. A Practical Guide for the Current Use of Biologic Therapies in Sports Medicine;The American Journal of Sports Medicine;2019-04-30

5. Proceedings of the signature series symposium “cellular therapies for orthopaedics and musculoskeletal disease proven and unproven therapies—promise, facts and fantasy,” international society for cellular therapies, montreal, canada, may 2, 2018;Cytotherapy;2018-11

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3